Cilostazol
Cilostazol (OPC 21) is a selective phosphodiesterase 3 (PDE3) inhibitor. It is widely used in research to study vasodilation, inhibition of platelet aggregation, and cellular proliferation in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
73963-72-1
Product Name Alternative
Cilostazol, Autophagy, cardiovascular, fibrogenesis, hepatic, Inhibitor, injury, late, inhibit, PDE3, OPC21, OPC-21, OPC13013, OPC-13013, OPC 21, OPC 13013, phosphodiesterase, Phosphodiesterase (PDE)
Field of Research
Cell Biology, Metabolism Research, Pharmacology & Drug Discovery
Purity
>98%
Bioactivity
Phosphodiesterase PDE3A inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 20 mg/ml) .
Smiles
C (CCCOC=1C=C2C (=CC1) NC (=O) CC2) C=3N (N=NN3) C4CCCCC4
Molecular Formula
C20H27N5O2
Molecular Weight
369.5
Storage Conditions
RT
Notes
For research use only.
Other Product Names
6-[4- (1-Cyclohexyl-1H-tetrazol-5-yl) -butoxy]-3,4-dihydro-2 (1H) -quinolinone
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog